Evidence map›Paper›PMID 28752501›Full record

ArticleJournal of neuro-oncology2017

Prognostic value of ion channel genes in Chinese patients with gliomas based on mRNA expression profiling.

Feng-Fei Lu, Hao-Yuan Wang, Xiao-Zheng He, Ting-Yu Liang, Wen Wang, Hui-Min Hu, Fan Wu, Yan-Wei Liu, Shi-Zhong Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Feng-Fei LuDepartment of Neurosurgery, Zhujiang Hospital, Southern Medical University, 253# Gongye Road, Guangzhou, China.
Hao-Yuan WangDepartment of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Meishan Road 81, Hefei, 230032, Anhui, China.
Xiao-Zheng HeDepartment of Neurosurgery, Zhujiang Hospital, Southern Medical University, 253# Gongye Road, Guangzhou, China.
Ting-Yu LiangBeijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Wen WangBeijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Hui-Min HuBeijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Fan WuBeijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Yan-Wei LiuBeijing Neurosurgical Institute, Capital Medical University, Beijing, China. liuyanwei_tiantan@163.com.
Shi-Zhong ZhangDepartment of Neurosurgery, Zhujiang Hospital, Southern Medical University, 253# Gongye Road, Guangzhou, China. zhangshizhong@smu.edu.cn.ORCID http://orcid.org/0000-0001-8408-2960
Capital Medical University · CNZhujiang Hospital · CN

Funding

Guangdong Provincial Clinical Medical Centre for Neurosurgery 2013B020400005
6 · The paper itself

Abstract

Increasing evidence suggests that ion channels not only regulate electric signaling in excitable cells but also play important roles in the development of human cancer. However, the roles of ion channels in glioma remain controversial. We systematically analyzed the expression patterns of ion channel genes in a cohort of Chinese patients with glioma using whole-genome mRNA expression profiling. First, a molecular signature comprising 47 ion channel genes (IC47) was identified using Spearman's rank correlation test conducted between tumor grade and gene expression. We assigned a risk score based on IC47 to each glioma patient. We demonstrated that the risk score effectively predicted overall survival in glioma patients. Next, we screened IC47 in different molecular glioma subtypes. IC47 showed a Mesenchymal subtype and wild-type IDH1 preference. Gene ontology (GO) analysis and gene set variation analysis (GSVA) for the functional annotation of IC47 showed that patients with high-risk scores tended to exhibit the decreased expression of proteins associated with the apoptosis and cell adhesion, and higher expression of proteins associated with the cell cycle and cell proliferation. These results suggest that ion channel gene expression could improve the subtype classification in gliomas at the molecular level. The findings in the present study have been validated in two independent cohorts.

Indexed as

Biomarkers, TumorBrain NeoplasmsFollow-Up StudiesGene Expression ProfilingGenetic Association StudiesGenetic TestingGliomaHumansIon ChannelsIsocitrate DehydrogenaseMicroarray AnalysisMutationNeoplasm GradingPrognosisRNA, MessengerBiomarkers, TumorIDH1 protein, humanIon ChannelsIsocitrate DehydrogenaseRNA, MessengerGliomaIDH1 mutationIon channel genesRisk scoreWhole-genome mRNA expression

Identifiers

PMID28752501
OpenAlexW2740648743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.